These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


294 related items for PubMed ID: 12451366

  • 21. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J.
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [Abstract] [Full Text] [Related]

  • 22. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S, Cox SE, Finn JC, Werschler WP, Kowalski JW.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [Abstract] [Full Text] [Related]

  • 23. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC.
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [Abstract] [Full Text] [Related]

  • 24. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K.
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [Abstract] [Full Text] [Related]

  • 25. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
    Baumann L, Slezinger A, Vujevich J, Halem M, Bryde J, Black L, Duncan R.
    Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
    [Abstract] [Full Text] [Related]

  • 26. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I, Modi P, Chajchir A.
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [Abstract] [Full Text] [Related]

  • 27. Botox in men.
    Flynn TC.
    Dermatol Ther; 2007 Sep; 20(6):407-13. PubMed ID: 18093014
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC, Carruthers JA, Carruthers JA, Clark RE.
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
    Gassia V.
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.